This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...